Molecular Epidemiology and Clinical Characterization of Carbapenemase-Producing Enterobacter Species From an International Cohort
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae616 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Jianping Jiang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey. Hauptthemen laut MEDLINE: Bacterial Proteins, beta-Lactamases, Carbapenem-Resistant Enterobacteriaceae, Enterobacter. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, BLRD VA.
Abstract (Originalsprache)
Background
Despite the global public health threat posed by carbapenem-resistant Enterobacter spp, clinical and molecular epidemiological studies on international isolates remain scarce. Historically, the taxonomy of Enterobacter has been challenging, limiting our understanding of the clinical characteristics and outcomes of carbapenemase-producing Enterobacter spp infections.
Methods
Hospitalized patients enrolled in the CRACKLE-2 study (ClinicalTrials.gov, NCT03646227) from 2016 to 2018 with cultures positive for carbapenemase-producing Enterobacter spp were included. Clinical and microbiologic data were collected from health records. Whole genome sequencing was performed, and the population structures of selected predominant clones were analyzed.
Results
We enrolled 136 hospitalized patients with carbapenemase-producing Enterobacter spp from 30 hospitals in 7 countries. Among the 136 isolates, 11 Enterobacter spp were identified, with most isolates belonging to E xiangfangensis (n = 81 [60%]) and E hoffmannii (n = 17 [13%]) and carrying blaKPC (n = 106 [78%]) and blaNDM (n = 12 [9%]). Clinical characteristics and outcomes were similar among patients with E xiangfangensis, E hoffmannii, or the other Enterobacter spp. Thirty-day mortality was 20%, and older age at enrollment (adjusted odds ratio, 1.42 [95% confidence interval, 1.08–1.87]) was associated with increased mortality. Sequence type (ST) 171 E xiangfangensis, ST78 E hoffmannii, and ST93 E xiangfangensis were the predominant clones, and the acquisition of fluoroquinolone resistance–associated mutations and carbapenemase-encoding plasmids contributed to their formation and global dissemination.
Conclusions
Our findings demonstrate that E xiangfangensis and E hoffmannii are common species among international carbapenemase-producing Enterobacter spp, potentially linked to the clonal spread of a few predominant clones that have acquired fluoroquinolone resistance and carbapenemase-encoding plasmids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey.
- The Biostatistics Center, George Washington University, Rockville, Maryland.
- Duke Clinical Research Institute, Duke University, Durham, North Carolina.
- Center for Infectious Diseases and Microbial Genomics, UTHealth, McGovern School of Medicine at Houston.
- Division of Infectious Diseases and Center for Infectious Diseases Research, Houston Methodist Hospital and Houston Methodist Research Institute, Houston, Texas.
- Department of Medicine, Weill Cornell Medical College, New York, New York.
ORCID-Profile: Jianping Jiang, Angelique E Boutzoukas, Blake Hanson, Robert A Bonomo, Scott Evans, Yohei Doi, Gregory Weston, Soraya Salcedo Mendoza, Paul Ananth Tambyah, Henry F Chambers, Vance G Fowler, David van Duin, Barry N Kreiswirth
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- BLRD VA
- (NIAID)
- NIH HHS
- National Institutes of Health
Zitieren
APA
Jiang, J., Komarow, L., Hill, C., Boutzoukas, A. E., Hanson, B., Arias, C. A., Bonomo, R. A., Evans, S., Doi, Y., Satlin, M. J., Weston, G., Cober, E., Valderrama-Beltran, S. L., Mendoza, S. S., Liu, Z., Fries, B. C., Tambyah, P. A., Chambers, H. F., Fowler, V. G., …, & Chen, L. (2025). Molecular Epidemiology and Clinical Characterization of Carbapenemase-Producing Enterobacter Species From an International Cohort. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae616
Vancouver
Jiang J, Komarow L, Hill C, Boutzoukas AE, Hanson B, Arias CA, et al. Molecular Epidemiology and Clinical Characterization of Carbapenemase-Producing Enterobacter Species From an International Cohort. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae616
BibTeX
@article{Jiang2025,
author = {Jiang, Jianping and Komarow, Lauren and Hill, Carol and Boutzoukas, Angelique E and Hanson, Blake and Arias, Cesar A and Bonomo, Robert A and Evans, Scott and Doi, Yohei and Satlin, Michael J and Weston, Gregory and Cober, Eric and Valderrama-Beltran, Sandra Liliana and Mendoza, Soraya Salcedo and Liu, Zhengyin and Fries, Bettina C and Tambyah, Paul Ananth and Chambers, Henry F and Fowler, Vance G and van Duin, David and Kreiswirth, Barry N and Chen, Liang},
title = {Molecular Epidemiology and Clinical Characterization of Carbapenemase-Producing Enterobacter Species From an International Cohort},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae616}
}
EUVIMED